Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis

Introduction Despite better therapies and strategies, many people with rheumatoid arthritis (RA) have persistent pain, often from abnormal pain processing, now termed nociplastic pain. However, RA patients with fibromyalgia (FM), a central nociplastic pain syndrome, also have power doppler ultrasoun...

Full description

Bibliographic Details
Main Authors: Sam Norton, Bruce W Kirkham, James Galloway, Khaldoun Chaabo, Toby Garrood, Zoe Rutter-Locher, Estee Chan, Alex Vincent
Format: Article
Language:English
Published: BMJ Publishing Group 2024-02-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/10/1/e003784.full
_version_ 1797222192717496320
author Sam Norton
Bruce W Kirkham
James Galloway
Khaldoun Chaabo
Toby Garrood
Zoe Rutter-Locher
Estee Chan
Alex Vincent
author_facet Sam Norton
Bruce W Kirkham
James Galloway
Khaldoun Chaabo
Toby Garrood
Zoe Rutter-Locher
Estee Chan
Alex Vincent
author_sort Sam Norton
collection DOAJ
description Introduction Despite better therapies and strategies, many people with rheumatoid arthritis (RA) have persistent pain, often from abnormal pain processing, now termed nociplastic pain. However, RA patients with fibromyalgia (FM), a central nociplastic pain syndrome, also have power doppler ultrasound (PDUS+) joint inflammation. To understand the complex causes of pain, we performed clinical examination and patient-reported outcome measures (PROMs) plus comprehensive PDUS evaluation not previously combined.Methods In a cross-sectional study of sequential RA patients with at least moderate DAS28 erythrocyte sedimentation rate disease activity, we assessed 66/68 joints for swelling and tenderness, respectively, FM American College of Rheumatology 2010 diagnostic criteria, completed PROMs for function, quality of life and mood, alongside PDUS examination of 44 joints. Statistical analysis included logistic regression modelling and regularised (lasso) logistic regression methods.Results From 158 patients, 72 (46%) patients met FM criteria, with significantly worse tender joint counts and PROMs, but no differences in PDUS compared with the non-FM group. Categorising patients by PDUS+ joint presence and/or FM criteria, we identified four distinct groups: 43 (27.2%) patients with −FM−PD, 43 (27.2%) with −FM+PD, 42 (26.6%) with +FM−PD and 30 (19%) with +FM+PD. Both FM+ groups had worse PROMs for fatigue, mood and pain, compared with the FM− groups. We were unable to develop algorithms to identify different groups.Conclusion The unexpected group −FM−PD group may have peripheral nociplastic pain, not commonly recognised in rheumatology. Only 46% of patients demonstrated PDUS+ inflammation. However clinical examination and PROMs did not reliably differentiate groups, emphasising PDUS remains an important tool.
first_indexed 2024-04-24T13:17:26Z
format Article
id doaj.art-9f332f35f41242d5b9cf229f9367f721
institution Directory Open Access Journal
issn 2056-5933
language English
last_indexed 2024-04-24T13:17:26Z
publishDate 2024-02-01
publisher BMJ Publishing Group
record_format Article
series RMD Open
spelling doaj.art-9f332f35f41242d5b9cf229f9367f7212024-04-04T17:20:07ZengBMJ Publishing GroupRMD Open2056-59332024-02-0110110.1136/rmdopen-2023-003784Pain sensitisation and joint inflammation in patients with active rheumatoid arthritisSam Norton0Bruce W Kirkham1James Galloway2Khaldoun Chaabo3Toby Garrood4Zoe Rutter-Locher5Estee Chan6Alex Vincent7Academic Department of Rheumatology, King`s College London, London, UKRheumatology, Guy`s and St Thomas` Hospitals NHS Trust, London, UKAcademic Department of Rheumatology, King`s College London, London, UKRheumatology, Guy`s and St Thomas` Hospitals NHS Trust, London, UKRheumatology, Guy`s and St Thomas` Hospitals NHS Trust, London, UKRheumatology, Guy`s and St Thomas` Hospitals NHS Trust, London, UKRheumatology, Guy`s and St Thomas` Hospitals NHS Trust, London, UKGuy`s and St Thomas` Hospitals NHS Trust, London, UKIntroduction Despite better therapies and strategies, many people with rheumatoid arthritis (RA) have persistent pain, often from abnormal pain processing, now termed nociplastic pain. However, RA patients with fibromyalgia (FM), a central nociplastic pain syndrome, also have power doppler ultrasound (PDUS+) joint inflammation. To understand the complex causes of pain, we performed clinical examination and patient-reported outcome measures (PROMs) plus comprehensive PDUS evaluation not previously combined.Methods In a cross-sectional study of sequential RA patients with at least moderate DAS28 erythrocyte sedimentation rate disease activity, we assessed 66/68 joints for swelling and tenderness, respectively, FM American College of Rheumatology 2010 diagnostic criteria, completed PROMs for function, quality of life and mood, alongside PDUS examination of 44 joints. Statistical analysis included logistic regression modelling and regularised (lasso) logistic regression methods.Results From 158 patients, 72 (46%) patients met FM criteria, with significantly worse tender joint counts and PROMs, but no differences in PDUS compared with the non-FM group. Categorising patients by PDUS+ joint presence and/or FM criteria, we identified four distinct groups: 43 (27.2%) patients with −FM−PD, 43 (27.2%) with −FM+PD, 42 (26.6%) with +FM−PD and 30 (19%) with +FM+PD. Both FM+ groups had worse PROMs for fatigue, mood and pain, compared with the FM− groups. We were unable to develop algorithms to identify different groups.Conclusion The unexpected group −FM−PD group may have peripheral nociplastic pain, not commonly recognised in rheumatology. Only 46% of patients demonstrated PDUS+ inflammation. However clinical examination and PROMs did not reliably differentiate groups, emphasising PDUS remains an important tool.https://rmdopen.bmj.com/content/10/1/e003784.full
spellingShingle Sam Norton
Bruce W Kirkham
James Galloway
Khaldoun Chaabo
Toby Garrood
Zoe Rutter-Locher
Estee Chan
Alex Vincent
Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis
RMD Open
title Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis
title_full Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis
title_fullStr Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis
title_full_unstemmed Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis
title_short Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis
title_sort pain sensitisation and joint inflammation in patients with active rheumatoid arthritis
url https://rmdopen.bmj.com/content/10/1/e003784.full
work_keys_str_mv AT samnorton painsensitisationandjointinflammationinpatientswithactiverheumatoidarthritis
AT brucewkirkham painsensitisationandjointinflammationinpatientswithactiverheumatoidarthritis
AT jamesgalloway painsensitisationandjointinflammationinpatientswithactiverheumatoidarthritis
AT khaldounchaabo painsensitisationandjointinflammationinpatientswithactiverheumatoidarthritis
AT tobygarrood painsensitisationandjointinflammationinpatientswithactiverheumatoidarthritis
AT zoerutterlocher painsensitisationandjointinflammationinpatientswithactiverheumatoidarthritis
AT esteechan painsensitisationandjointinflammationinpatientswithactiverheumatoidarthritis
AT alexvincent painsensitisationandjointinflammationinpatientswithactiverheumatoidarthritis